S. Rigatos

发表

Surgical management in lung metastases from colorectal cancer.

G. Papadopoulos, G. Stathopoulos, J. Stathopoulos, 2007, Anticancer research.

Phase I I T rial o f B iweekly A dministration o f V inorelbine and G emcitabine i n P retreated A dvanced B reast C ancer

G. Stathopoulos, J. Stathopoulos, N. Pergantas, 2002 .

Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: a phase II study of the Greek Cooperative Group for Pancreatic Cancer.

S. Agelaki, V. Georgoulias, D. Mavroudis, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Paclitaxel and liposomal doxorubicin (Caelyx) combination in advanced breast cancer patients: a phase II study.

G. Stathopoulos, J. Stathopoulos, A. Athanasiadis, 2003, Oncology reports.

Phase II trial of biweekly administration of vinorelbine and gemcitabine in pretreated advanced breast cancer.

G. Stathopoulos, J. Stathopoulos, N. Pergantas, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Weekly administration of topotecan and paclitaxel in pretreated advanced cancer patients: a phase I/II study

D. Skarlos, C. Christodoulou, G. Stathopoulos, 2004, Cancer Chemotherapy and Pharmacology.

Investigation of doxorubicin tissue toxicity: does amifostine provide chemoprotection? An experimental study.

I. Dontas, P. Karayannacos, G. Stathopoulos, 2002, Anticancer research.

Front-line paclitaxel-vinorelbine versus paclitaxel-carboplatin in patients with advanced non-small-cell lung cancer: a randomized phase III trial.

K. Vergos, S. Loukides, G. Stathopoulos, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Mesothelioma: treatment and survival of a patient population and review of the literature.

G. Stathopoulos, D. Antoniou, J. Dimitroulis, 2005, Anticancer research.

Comparison of cisplatin-paclitaxel combination versus cisplatin-etoposide in patients with small-cell lung cancer: a Phase III study.

A. Rapti, G. Stathopoulos, D. Antoniou, 2008, Oncology reports.

Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase II study.

K. Syrigos, G. Fountzilas, N. Ziras, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer.

M. Dimopoulos, S. Agelaki, V. Georgoulias, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Pegylated liposomal doxorubicin hydrochloride (PLD) and paclitaxel in recurrent or metastatic head and neck carcinoma: a phase I/II study conducted by the Hellenic Cooperative Oncology Group (HeCOG)

M. Dimopoulos, G. Aravantinos, G. Fountzilas, 2004, Anti-cancer drugs.

Second-line chemotherapy in small cell lung cancer in a modified administration of topotecan combined with paclitaxel: a phase II study

D. Skarlos, C. Christodoulou, G. Stathopoulos, 2006, Cancer Chemotherapy and Pharmacology.

Adjuvant Chemotherapy for Colon Cancer: Evidence on Improvement in Survival

C. Dervenis, E. Samantas, S. Rigatos, 2007, Digestive Diseases.

Long-term survival of patients with advanced colorectal cancer may not be due to the response to chemotherapy.

G. Stathopoulos, J. Stathopoulos, F. Antoniou, 2004, Oncology reports.

Efficacy and Tolerability of Oxaliplatin Plus Irinotecan 5-Fluouracil and Leucovorin Regimen in Advanced Stage Colorectal Cancer Patients Pretreated With Irinotecan 5-Fluouracil and Leucovorin

G. Stathopoulos, J. Stathopoulos, E. Dimou, 2005, American journal of clinical oncology.